Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Humira
Humira
AbbVie says Humira sales will balloon to $21 bln in 2020, shares rise
Yahoo/Reuters
Fri, 10/27/17 - 11:05 am
AbbVie
Humira
earnings
AbbVie boasts a PhIII sweep for top psoriasis contender risankizumab, but it has lots of competition
Endpoints
Thu, 10/26/17 - 09:28 am
AbbVie
psoriasis
risankizumab
Humira
Stelara
clinical trials
Pfizer's Lyrica takes pharma TV spending crown from AbbVie's Humira for September
Fierce Pharma
Mon, 10/9/17 - 11:24 am
Pfizer
Lyrica
AbbVie
Humira
drug ads
television ads
3 Big Pharma Stocks Set to Succeed
Motley Fool
Thu, 10/5/17 - 09:36 am
AbbVie
Humira
patents
Allergan
Botox
Celgene
Revlimid
Abbvie, Amgen Deal on Humira Biosimilars Likely to Cost CMS More Than $1B
RAPS.org
Mon, 10/2/17 - 11:18 am
AbbVie
Amgen
Humira
biosimilars
Medicare
Medicaid
CMS
How Good Is AbbVie's Humira Deal With Amgen?
Motley Fool
Fri, 09/29/17 - 10:06 am
AbbVie
Amgen
Humira
biosimilars
Amjevita
Under Amgen and AbbVie agreement, rival drug to AbbVie's Humira expected to launch in 2023
Marketwatch
Thu, 09/28/17 - 09:50 am
Amgen
AbbVie
Humira
Amgevita
biosimilars
drug launches
AbbVie's Unfazed by the Risk of Generic Humira
Motley Fool
Mon, 09/25/17 - 09:45 am
AbbVie
generics
Humira
AbbVie’s top execs paint a rosy pic of the mega-blockbuster future looming for Humira and PhIII drugs
Endpoints
Fri, 09/22/17 - 09:19 am
AbbVie
Humira
Rick Gonzalez
Which of These 5 Will Be the Best-Selling Drug Worldwide in 2020?
Motley Fool
Sat, 09/16/17 - 12:01 pm
AbbVie
Humira
Celgene
Revlimid
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Biogen
aducanumab
This Shield of Patents Protects the World’s Best-Selling Drug
Bloomberg
Fri, 09/8/17 - 09:25 am
patents
AbbVie
Humira
Biogen, Samsung Humira copy wins EU approval
Fierce Pharma
Fri, 08/25/17 - 09:52 am
Biogen
Samsung Bioepis
Europe
Humira
AbbVie
Imraldi
biosimilars
The decade's top 10 patent losses, worth a whopping $915B in lifetime sales
Fierce Pharma
Thu, 08/17/17 - 10:36 am
patents
AbbVie
Humira
Pfizer
Lipitor
Norvasc
GSK
Advair
Sanofi
Lantus
JNJ
Remicade
AstraZeneca
Crestor
Nexium
Amgen
Neulasta
Novartis
Diovan
Humira may spend most on TV, but Xeljanz, Taltz and Breo notch highest view rates
Fierce Pharma
Thu, 08/10/17 - 10:47 am
Humira
Xeljanz
Taltz
Breo
drug ads
television ads
DTC ads
AbbVie confident in strategy as Humira mints money
BioPharma Dive
Sat, 07/29/17 - 09:44 am
AbbVie
Humira
Novartis stocks drug cabinet with "Big-3" arthritis blockbusters
Yahoo/Reuters
Fri, 07/14/17 - 07:58 am
Novartis
rheumatoid arthritis
generics
Sandoz
Amgen
Enbrel
JNJ
Remicade
AbbVie
Humira
Key Humira patent gets struck down for the second time in as many months
Fierce Pharma
Sun, 07/9/17 - 11:38 am
Humira
patents
AbbVie
Boehringer Ingelheim
Coherus Biosciences
Lilly’s Olumiant, spurned by FDA, gets nod from NICE
Fierce Pharma
Sat, 07/1/17 - 09:26 am
FDA
NICE
Europe
Eli Lilly
olumiant
rheumatoid arthritis
Humira
The 9 Best-Selling Prescription Drugs in 2016 (Each One Topped $6 Billion)
Motley Fool
Fri, 06/30/17 - 11:06 am
prescription data
Sanofi
Lantus
Roche
Herceptin
Avastin
Celgene
Revlimid
JNJ
Merck
Remicade
Biogen
Rituxan
Amgen
Enbrel
Gilead Sciences
Harvoni
AbbVie
Humira
[video]Will AbbVie Outsmart Biosimilars, and Can Clovis Win the PARP Race?
Motley Fool
Tue, 06/27/17 - 09:45 am
AbbVie
biosimilars
Humira
Clovis Oncology
Rubraca
Novartis
Regeneron
Eylea
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »